Results 1 to 10 of about 412,675 (264)
Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine
S I, Rennard, D M, Daughton
openaire +5 more sources
Smoking increases the risk of postoperative morbidity and mortality. Smoking cessation before surgery reduces the risk of complications. The perioperative period may be a “teachable moment” for smoking cessation and provides smokers an opportunity to engage in long-term smoking cessation.
Elizabeth V, Ratchford, Natalie S, Evans
openaire +4 more sources
Cigarette smoking is the primary cause of chronic obstructive pulmonary disease, and smoking cessation is the most effective means of stopping the progression of chronic obstructive pulmonary disease. Worldwide, approximately a billion people smoke cigarettes and 80% reside in low-income and middle-income countries.
Scott P, Marlow, James K, Stoller
openaire +5 more sources
Understanding the role of cessation fatigue in the smoking cessation process [PDF]
To understand the dynamic process of cessation fatigue (i.e., the tiredness of trying to quit smoking) with respect to its average trend, effect on relapse, time-varying relations with craving and negative affect, and differences among genders and treatment groups.Randomized placebo-controlled clinical trial.
Xiaoyu, Liu +4 more
openaire +2 more sources
Incentives for smoking cessation [PDF]
Financial incentives (money, vouchers, or self-deposits) can be used to positively reinforce smoking cessation. They may be used as one-off rewards, or in various schedules to reward steps towards sustained smoking abstinence (known as contingency management).
Notley, Caitlin +6 more
openaire +4 more sources
Cytisine for smoking cessation [PDF]
Cytisine, primarily derived from the Cytisus laburnum plant (which inspired the development of varenicline), is a partial agonist of the α4β2 nicotinic acetylcholine receptor responsible for central effects of nicotine.[1][1] Oral cytisine reaches peak concentration two hours postdose[2][2] and ...
Taleen, Karnieg, Xiang, Wang
openaire +2 more sources
Incentives for smoking cessation [PDF]
Material or financial incentives are widely used in an attempt to precipitate or reinforce behaviour change, including smoking cessation. They operate in workplaces, in clinics and hospitals, and to a lesser extent within community programmes. In this third update of our review we now include trials conducted in pregnant women, to reflect the ...
Kate, Cahill +2 more
openaire +2 more sources
Contemporary Smoking Cessation [PDF]
Background Tobacco smoking is the single most preventable cause of death in the United States today. Oncologists are in a unique position to affect the health and economic burdens of smoking by encouraging cessation among their patients who smoke. Methods
J L, Westmaas, V, Nath, T H, Brandon
openaire +2 more sources
Smoking cessation and vaccination
A significant proportion of COPD patients (∼40%) continue smoking despite knowing that they have the disease. Smokers with COPD exhibit higher levels of nicotine dependence, and have lower self-efficacy and self-esteem, which affects their ability to quit smoking.
Montes de Oca, Maria +1 more
openaire +2 more sources
Antidepressants for smoking cessation [PDF]
There are at least three reasons to believe antidepressants might help in smoking cessation. Firstly, nicotine withdrawal may produce depressive symptoms or precipitate a major depressive episode and antidepressants may relieve these. Secondly, nicotine may have antidepressant effects that maintain smoking, and antidepressants may substitute for this ...
Hughes, JR +4 more
openaire +2 more sources

